GABA/benzodiazepine receptors in the ventromedial hypothalamic nucleus regulate both anxiety and panic-related defensive responses in the elevated T-maze

Brain Research Bulletin

Volumn 74, Issue 1-3, 2007, Pages 134-141

  Bueno, Cíntia Heloína ^a   Zangrossi Jr , Hélio ^a   Viana, Milena de Barros ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Elevated T maze; Escape; GABA; Generalized anxiety; Inhibitory avoidance; Panic; Ventromedial hypothalamus

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BACLOFEN; BENZODIAZEPINE RECEPTOR; MIDAZOLAM; MUSCIMOL; N METHYL BETA CARBOLINE 3 CARBOXAMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; EVOKED RESPONSE; HISTOPATHOLOGY; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PANIC; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CARBOLINES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; GABA AGONISTS; GABA ANTAGONISTS; GABA MODULATORS; MALE; MAZE LEARNING; MIDAZOLAM; MUSCIMOL; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, GABA-A; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 34547549779     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2007.06.003     Document Type: Article

References (52)

1. Adamec R.E. Evidence that NMDA-dependent limbic neural plasticity in the right hemisphere mediates pharmacological stressor (FG-7142)-induced lasting increases in anxiety-like behavior: study 3-the effects on amygdala efferent physiology of block of NMDA receptors prior to injection of FG-7142 and its relationship to behavioral change. J. Psychopharmacol. 12 3 (1998) 227-238
2. Adamec R.E., and Stark-Adamec C. Partial kindling and emotional bias in the cat: lasting aftereffects of partial kindling of the ventral hippocampus. II. Physiological changes. Behav. Neural Biol. 38 2 (1983) 223-239
3. Adamec R.E., and Young B. Neuroplasticity in specific limbic system circuits may mediate specific kindling induced changes in animal affect-implications for understanding anxiety associated with epilepsy. Neurosci. Biobehav. Rev. 24 7 (2000) 705-723
4. Agmo A., and Fernandez H. Benzodiazepine receptor ligands and sexual behavior in the male rat: the role of GABAergic mechanisms. Pharmacol. Biochem. Behav. 38 4 (1991) 781-788
5. Blanchard D.C., and Blanchard R.J. Ethoexperimental approaches to the biology of emotion. Ann. Rev. Psychol. 39 (1988) 43-68
6. Blanchard D.C., Canteras N.S., Markham C.M., Pentkowski N.S., and Blanchard R.J. Lesions of structures showing FOS expression to cat presentation: Effects on responsivity to a Cat, Cat odor, and nonpredator threat. Neurosci. Biobehav. Rev. 29 (2005) 1243-1253
7. Blanchard D.C., Griebel G., and Blanchard R.J. Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci. Biobehav. Rev. 25 (2001) 205-218
8. Brandao M.L., Di Scala G., Bouchet M.J., and Schmitt P. Escape behavior produced by the blockade of glutamic acid decarboxylase (GAD) in mesencephalic central gray or medial hypothalamus. Pharmacol. Biochem. Behav. 24 3 (1986) 497-501
9. Breslow M.F., Fankhauser M.P., Potter R.L., Meredith K.E., Misiaszek J., and Hope Jr. D.G. Role of gamma-aminobutyric acid in antipanic drug efficacy. Am. J. Psychiatry 146 (1989) 353-356
10. B receptors in the dorsal periaqueductal grey of rats. Eur. J. Pharmacol. 516 3 (2005) 239-246
11. Canteras N. The medial hypothalamic defensive system: hodological organization and functional implications. Pharmacol. Biochem. Behav. 71 (2002) 481-491
12. Canteras N., Ribeiro-Barbosa E.R., and Comoli E. Tracing from the dorsal premamillary nucleus prosencephalic systems involved in the organization of innate fear responses. Neurosci. Biobehav. Rev. 25 (2001) 661-668
13. Choi G.B., Dong H.W., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Swanson L.W., and Anderson D.J. Lhx6 delineates a pathway mediating innate reproductive behaviors from the amygdala to the hypothalamus. Neuron 46 4 (2005) 525-526
14. Cullinan W.E., Helmreich D.L., and Watson S.J. Fos expression in forebrain afferents to the hypothalamic paraventricular nucleus following swim stress. J. Comp. Neurol. 368 (1996) 88-99
15. Davis A.M., Henion T.R., and Tobet S.A. Gamma-aminobutyric acid B receptors and the development of the ventromedial nucleus of the hypothalamus. J. Comp. Neurol. 449 3 (2002) 270-280
16. Deakin J.F., and Graeff F.G. 5-HT and mechanisms of defense. J. Psychopharmachol. (Berl.) 5 (1991) 305-315
17. Di Scala G., Schmitt P., and Karli P. Flight induced by infusion of bicuculline methiodine into periventricular structures. Brain Res. 309 (1984) 199-208
18. Dorow R., Horowski R., Paschelke G., Amin M., and Braestrup C. Severe anxiety induced by FG 7142 a beta carboline ligand for benzodiazepine receptors. Lancet 8342 (1983) 98-99
19. File S.E., and Zangrossi Jr. H. One-trial tolerance to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?. Psychopharmacology (Berl.) 110 1-2 (1993) 240-244
20. Graeff F.G. Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals. Braz. J. Med. Biol. Res. 27 (1994) 811-829
21. Graeff F.G., Netto C.F., and Zangrossi Jr. H. The elevated T-maze as an experimental model of anxiety. Neurosci. Biobehav. Rev. 23 (1998) 237-246
22. Graeff F.G., Viana M.B., and Tomaz C.A.B. The elevated T-maze, a new experimental model of anxiety and memory: effect of diazepam. Braz. J. Med. Biol. Res. 26 (1993) 67-70
23. Graeff F.G., and Zangrossi Jr. H. Animal models of anxiety. In: D'Haenen H., Den Boer J.A., and Willner P. (Eds). Biological Psychiatry (2002), John Wiley & Sons, London 1-15
24. Gray J.A., and McNaughton N. The Neuropsychology of Anxiety (2001), Oxford University Press, Oxford
25. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol. Ther. 65 3 (1995) 319-395
26. Herdade K.C.P., Strauss C.V.A., Zangrossi Jr. H., and Viana M.B. Effects of medial amygdala inactivation on a panic-related behavior. Behav. Brain Res. 172 (2006) 316-323
27. Hirasawa M., Nishihara M., and Takahashi M. Neural activity in the VMH associated with suppression of the circulatory system in rats. Physiol. Behav. 59 6 (1996) 1017-1023
28. Hosoi M., Oka T., Abe M., Hori T., Yamamoto H., Mine K., and Kubo C. Prostaglandin E(2) has antinociceptive effect through EP(1) receptor in the ventromedial hypothalamus in rats. Pain 83 2 (1999) 221-227
29. Hrabovszky E., Halász J., Meelis W., Kruk M.R., Liposits Z.S., and Haller J. Neurochemical characterization of hypothalamic neurons involved in attack behavior: glutamatergic dominance and co-expression of thyrotropin-releasing hormone in a subset of glutamatergic neurons. Neuroscience 133 (2005) 657-666
30. Jardim M.C., Aguiar F.A., and Guimarães F.S. Role of glutamate ionotropic and benzodiazepine receptors in the ventromedial hypothalamic nucleus on anxiety. Pharmacol. Biochem. Behav. 82 (2005) 182-189
31. Lammers J.H.C.M., Kruk M.R., Meelis W., and van der Poel A.M. Hypothalamic substrates for brain stimulation-induced patterns of locomotor and escape jumps in the rat. Brain Res. 449 1-2 (1988) 311-327
32. Malizia A.L., Coupland N.J., and Nutt D.J. In: Biggio G., Sanna E., Serra M., and Costa E. (Eds). GABAA Receptors and Anxiety: From Neurobiology to Treatment (1995), Raven Press, New York 115-133
33. McClellan K.M., Parker K.L., and Tobet S. Development of the ventromedial nucleus of the hypothalamus. Front. Neuroendocrinol. 27 2 (2006) 193-209
34. McNaughton N., and Corr P.J. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci. Biobehav. Rev. 28 (2004) 285-305
35. Milani H., and Graeff F.G. GABA-benzodiazepine modulation of aversion in the medial hypothalamus of the rat. Pharmacol. Biochem. Res. 28 (1987) 21-27
36. Ogawa S., Kow L.M., and Pfaff D.W. Effects of GABA and related agents on the electrical activity of hypothalamic ventromedial nucleus neurons in vitro. Exp. Brain Res. 85 1 (1991) 85-92
37. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, Sidney
38. Poltronieri S.C., Zangrossi Jr. H., and Viana M.B. Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behav. Brain Res. 147 (2003) 185-192
39. Priestley T. The effect of baclofen and somatostatin on neuronal activity in the rat ventromedial hypothalamic nucleus in vitro. Neuropharmacology 31 (1992) 103-109
40. Russo A.S., Guimaraes F.S., De Aguiar J.C., and Graeff F.G. Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety. Psychopharmacology (Berl.) 110 1-2 (1993) 198-202
41. Schmitt P., Di Scala G., Brandao M.L., and Karli P. Behavioral effects of microinjections of SR 95103, a new GABA-A antagonist, into the medial hypothalamus or the mesencephalic central gray. Eur. J. Pharmacol. 117 2 (1985) 149-158
42. Silveira M.C.L., and Graeff F.G. Defense reaction elicited by microinjection of kainic acid into the medial hypothalamus of the rat: antagonism by a GABAA receptor agonist. Behav. Neural Biol. 57 3 (1992) 226-232
43. Sulcova A., Krsiak M., and Donat P. Beta-CCE and FG 7142 increase defensiveness during intraspecies encounters in mice. Psychopharmacology (Berl.) 108 1-2 (1992) 205-209
44. Taguchi J., Kuriyama T., Ohmori Y., and Kuriyama K. Immunohistochemical studies on distribution of GABAA receptor complex in the rat brain using antibody against purified GABAA receptor complex. Brain Res. 483 2 (1989) 395-401
45. Takenaka K., Sasaki S., Nakamura K., Uchida A., Fujita H., Itoh H., Nakata T., Takeda K., and Nakagawa M. Hypothalamic and medullary GABAA and GABA-ergic systems differently regulate sympathetic and cardiovascular systems. Clin. Exp. Pharmacol. Physiol. Suppl. 22 1 (1995) S48-S50
46. Talalaenko A.N., Gordienko D.V., Pankrat'ev D.V., Zinkovich I.I., and Krivobok G.K. The role of neurochemical mechanisms of ventromedial hypothalamus in various models of anxiety in rats. Bull. Exp. Biol. Med. 131 1 (2001) 38-40
47. Teixeira R.C., Zangrossi Jr. H., and Graeff F.G. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol. Biochem. Behav. 65 (2000) 571-576
48. Thiebot M.H., Soubrie P., and Sanger D. Anxiogenic properties of beta-CCE and FG 7142 a review of promises and pitfalls. Psychopharmacology (Berl.) 94 4 (1988) 452-463
49. Vianna D.M.L., Borelli K.G., Ferreira-Netto C., Macedo C.E., and Brandão M.L. Fos-like immonoreactive neurons following electrical stimulation of the dorsal periaqueductal gray at freezing and escape thresholds. Brain Res. Bull. 62 (2003) 179-189
50. Viana M.B., Tomaz C.A.B., and Graeff F.G. The elevated T-maze: a new animal model of anxiety and memory. Pharmacol. Biochem. Behav. 49 3 (1994) 549-554
51. Zagrodzka J., Romaniuk A., Wieczorek A.M., and Boguszewski P. Bicuculline administration into ventromedial hypothalamus: effects on fear and regional brain monoamines and GABA concentrations in rats. Acta Neurobiol. Exp. (Wars) 60 3 (2000) 333-343
52. Zangrossi Jr. H., and Graeff F.G. A behavioral validation of the elevated T-maze: a new animal model of anxiety. Brain Res. Bull. 44 (1997) 1-5